Company / Working Capital
Whitehawk Therapeutics, Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$134.5M
FY2025
5-year range
$44.2M / $161.2M
FY2021-FY2025
Trend
+204.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed +204% YoY in FY2025, a notable deviation from the 7-year average annual change of +47%.
Based on SEC 10-K filings.
$134M in FY2025 with a 5-year CAGR of +25.7%.
Improved from $98M to $134M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- +25.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +25.7%, indicating consistent growth.
- In FY2025, working capital increased 204.2% year-over-year.
- Peak working capital was recorded in FY2022.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $134.5M | +204.2% |
| FY2024 | $44.2M | -55.0% |
| FY2023 | $98.2M | -39.1% |
| FY2022 | $161.2M | +18.5% |
| FY2021 | $136.0M | +217.4% |
| FY2020 | $42.9M | +18.3% |
| FY2019 | $36.2M | -38.1% |
| FY2018 | $58.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026